RNA Outsourcing Resources

  1. Cryoport Systems Global Supply Chain Center: Ready For Launch! 6/6/2022

    Cell & gene therapies are rapidly outpacing the industry's limited manufacturing capacity. Learn more about the developing network of supply chain centers built to support this growing client base.

  2. Expertise In RNA Therapies: Client Success Stories 2/17/2023

    Learn how to navigate the complex challenges of accelerating therapies through clinical development to regulatory approval and commercialization.

  3. Why US Pharma Manufacturing Delivers Strategic Value 7/28/2026

    Domestic pharmaceutical manufacturing strengthens supply chain resilience, simplifies distribution, speeds market response, and reduces risk by aligning production with key markets.

  4. Solving Key Gene Therapy Logistics Challenges With Advanced Technology 1/8/2025

    Discover how cutting-edge logistics innovations are redefining gene therapy transportation to ensure safety, efficiency, and sustainability.

  5. A New Centre For Continuous mRNA Manufacturing 5/14/2024

    Explore how a partnership between academia, regulatory agencies, and manufacturing organizations has the potential to reshape the way we produce and distribute mRNA-based therapies.

  6. Transparent Pricing In Bioanalysis: A Feature, Not A Bonus 3/9/2026

    Unclear CRO pricing leaves small biotechs vulnerable to budget swings. Transparent, itemized costs cut financial risk, sharpen planning, and build trust by setting expectations from the start.

  7. 5 Questions That Put Sponsors Back in Control of Bioanalysis Projects 12/9/2025

    Bioanalysis service quality significantly impacts project success. Don't settle for typical CRO claims; demand better technology, pricing transparency, and dedicated partnership.

  8. Scaling For What's Next In EMEA 12/29/2025

    Scaling cell and gene therapy operations in EMEA demands strategic planning, regulatory alignment, and robust logistics to meet growing demand and ensure consistent delivery across diverse markets.

  9. Validate Cryopreservation As A Defined Input, Not A Variable 4/28/2026

    Treating cryopreservation as a validated, controlled input improves consistency, quality, and patient outcomes by reducing variability across cell therapy manufacturing, storage, and distribution.

  10. Meeting The Challenges Of Gene Therapy Logistics With The Cryoport Elite Ultra Cold 1/8/2025

    Explore how innovative logistics solutions are addressing the critical challenges of gene therapy transportation to ensure safe, reliable delivery of these life-changing treatments.